Enzolytics Inc (ENZC)

[docsetc]

Paul Fellegy is an interesting name on there. He was helping coordinate some of the lab operations in A&M's campus, and he's living in an apartment/condo in College Station now, near the campus. Looks to me, since Charles kept IP and researchers as company officers, and no lab at present, but a connection to Samsung's main campus in Korea, that his new company is probably ready, if not already, producing the Clone 3 & 7 antibodies for private trials.
(Something that should have happened long ago.)

And you're right, starting this in 2023, was pure covert activity, fast at that. Harry and SAGA either complied for a piece of the new company success and we don't know about it, or Charles had them beat down good in some form of legal manner. It's also possible there is a settlement side-deal, where Charles' new company will provide Clone3 for the IPV-1 combo treatments, thereby also making Harry richer as a compound cure formula. This was proposed in earlier PR's.

Just look at the timing and positioning, they have a Samsung in Korea campus lab option now, the IP's clean and away from ENZC (probably, I know I'm speculating here) researchers and operations going on now, coordinated out of Charles' house, and they've kept folks they would have otherwise gotten rid of. Like I said, keep your eyes on Monoclonal Antibody Tech in the coming weeks and months. If I were Charles, at this point and with his own age, I'd be ready to move fast. My gut tells me they now have both Clone3 and Clone7 refined to a releasable market product, just need approvals and partners. And now, Samsung may really be a partner.

GLTA